- Patent Title: Aqueous formulation containing 5-aminolevulinic acid or the like
-
Application No.: US16326733Application Date: 2017-08-23
-
Publication No.: US10675242B2Publication Date: 2020-06-09
- Inventor: Mika Morishita , Urara Ota , Masahiro Ishizuka
- Applicant: SBI PHARMACEUTICALS CO., LTD.
- Applicant Address: JP Tokyo
- Assignee: SBI PHARMACEUTICALS, CO., LTD.
- Current Assignee: SBI PHARMACEUTICALS, CO., LTD.
- Current Assignee Address: JP Tokyo
- Agency: Myers Bigel, P.A.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@50eed113
- International Application: PCT/JP2017/030107 WO 20170823
- International Announcement: WO2018/043240 WO 20180308
- Main IPC: A61K9/08
- IPC: A61K9/08 ; A61K47/02 ; A61K31/197 ; A61K47/12 ; A61K31/22 ; A61K9/06 ; A61K31/295
Abstract:
The object of the invention is to elevate the stability of an aqueous formulation comprising ALAs and an iron compound. The present invention provides an aqueous formulation comprising ALAs and an iron compound, characterized in that it further comprises 0.2-30% by weight of salts, said salts are sodium salts or potassium salts, and the pH of said aqueous formulation is 2-8.
Public/Granted literature
- US20190201336A1 AQUEOUS FORMULATION CONTAINING 5-AMINOLEVULINIC ACID OR THE LIKE Public/Granted day:2019-07-04
Information query
